HIV-associated anal squamous cell cancer: an otherwise preventable disease.
Konstantinopoulos
Panagiotis A
PA
Division of Hematology/Oncology, and Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Schlecht
Hans P
HP
Bryan
Bradley
B
Pantanowitz
Liron
L
Dezube
Bruce J
BJ
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D001005:Anus Neoplasms / Q000473:pathology / Q000628:therapy* / Q000821:virology*; D016190:Carboplatin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000628:therapy* / Q000821:virology*; D017024:Chemotherapy, Adjuvant; D003125:Colostomy; D017809:Fatal Outcome; D005472:Fluorouracil / Q000008:administration & dosage; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D018451:Homosexuality, Male; D006801:Humans; D007813:Laparotomy; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D017239:Paclitaxel / Q000008:administration & dosage; D010166:Palliative Care / Q000379:methods; D018714:Radiotherapy, Adjuvant
D016685:Mitomycin; D016190:Carboplatin; D017239:Paclitaxel; D005472:Fluorouracil